Atypical meningiomas
- PMID: 32586495
- DOI: 10.1016/B978-0-12-822198-3.00043-4
Atypical meningiomas
Abstract
Meningiomas are the most common primary CNS tumor in adults, representing a third of brain lesions. Their clinical presentation varies greatly, ranging from asymptomatic incidental tumor to fatal tumor. The majority of meningiomas are benign, and gross total resection can achieve very low recurrence rates, with radiation therapy or radiosurgery reserved for recurrences or residual tumor that grows during serial imaging. At the other end of the spectrum, malignant meningiomas, although comprising just 1% of meningiomas, have been recognized to exhibit aggressive behavior that ultimately proves lethal regardless of the extent of resection or whether adjuvant radiation and chemotherapy are utilized. Over the past 2 decades, there has been pathologic recognition of a third type of meningioma known as "atypical," with borderline histologic and clinical features between benign and malignant meningioma. Here we review the clinical features, treatment, and outcomes of atypical meningiomas, with a focus on the impact of extent of resection and radiation therapy on the long-term recurrence rate of completely and incompletely resected atypical meningiomas.
Keywords: Atypical meningioma; Radiation; Radiosurgery; Skull base; WHO grade II.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria.Neurosurg Focus. 2008;24(5):E3. doi: 10.3171/FOC/2008/24/5/E3. Neurosurg Focus. 2008. PMID: 18447742
-
Intracranial meningiomas: an overview of diagnosis and treatment.Neurosurg Focus. 2007;23(4):E1. doi: 10.3171/FOC-07/10/E1. Neurosurg Focus. 2007. PMID: 17961033 Review.
-
Meningioma.Crit Rev Oncol Hematol. 2008 Aug;67(2):153-71. doi: 10.1016/j.critrevonc.2008.01.010. Epub 2008 Mar 14. Crit Rev Oncol Hematol. 2008. PMID: 18342535 Review.
-
Management of meningiomas.Clin Neurol Neurosurg. 2010 Apr;112(3):177-82. doi: 10.1016/j.clineuro.2009.12.011. Epub 2010 Jan 6. Clin Neurol Neurosurg. 2010. PMID: 20056312 Review.
-
Management of Atypical and Anaplastic Meningiomas.Neurosurg Clin N Am. 2016 Apr;27(2):239-47. doi: 10.1016/j.nec.2015.11.003. Epub 2016 Feb 20. Neurosurg Clin N Am. 2016. PMID: 27012388 Review.
Cited by
-
Improvement in visual outcomes of patients with base of skull meningioma as a result of evolution in the treatment techniques in the last three decades: a systematic review.J Neurooncol. 2023 Jul;163(3):485-503. doi: 10.1007/s11060-023-04366-8. Epub 2023 Jun 24. J Neurooncol. 2023. PMID: 37354356
-
Photodynamic Opening of the Blood-Brain Barrier and the Meningeal Lymphatic System: The New Niche in Immunotherapy for Brain Tumors.Pharmaceutics. 2022 Nov 26;14(12):2612. doi: 10.3390/pharmaceutics14122612. Pharmaceutics. 2022. PMID: 36559105 Free PMC article. Review.
-
The Use of Photodynamic Therapy in the Treatment of Brain Tumors-A Review of the Literature.Molecules. 2022 Oct 13;27(20):6847. doi: 10.3390/molecules27206847. Molecules. 2022. PMID: 36296440 Free PMC article. Review.
-
Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review.Front Oncol. 2022 May 31;12:892004. doi: 10.3389/fonc.2022.892004. eCollection 2022. Front Oncol. 2022. PMID: 35712492 Free PMC article. Review.
-
An evidence-based framework for postoperative surveillance of meningioma.Neurooncol Pract. 2024 Dec 2;12(3):478-488. doi: 10.1093/nop/npae117. eCollection 2025 Jun. Neurooncol Pract. 2024. PMID: 40487584 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous